'Spider-Man: Brand New Day' Eyes Third-Best U.S. 2nd Weekend With $143M – Box Office Update
Deadline
β’Sat, 08 Aug 2026 15:12:00 +0000
π° What Happened
Spider-Man: Brand New Day, directed by Destin Daniel Cretton, is on track for a massive $143M second weekend at the US box office, the third-best second frame ever and the largest for any Sony film. It's the eighth title overall and fifth Marvel movie to gross over $100M in its sophomore weekend. With a projected $653M 10-day cume, it would own the highest 10-day domestic gross in history, ahead of Avengers: Endgame.
π The Backstory
The film already posted a record-setting debut, buoyed by premium large-format and Imax screens driving a third of its second-weekend take. It follows the strong performance of The Odyssey, which recently crossed $1 billion at the worldwide box office.
π― Why It Matters
A blockbuster second weekend is a bright spot for cinemas at a time when moviegoing economics are under strain. For audiences, it signals Spider-Man: Brand New Day is a cultural event worth catching on the big screen, and it's a barometer for the health of the theatrical business.
Spider-Man: Brand New Day, directed by Destin Daniel Cretton, is on track for a massive $143M second weekend at the US box office, the third-best second frame ever and the largest for any Sony film. It's the eighth title overall and fifth Marvel movie to gross over $100M in its sophomore weekend. With a projected $653M 10-day cume, it would own the highest 10-day domestic gross in history, ahead of Avengers: Endgame.
The film already posted a record-setting debut, buoyed by premium large-format and Imax screens driving a third of its second-weekend take. It follows the strong performance of The Odyssey, which recently crossed $1 billion at the worldwide box office.
A blockbuster second weekend is a bright spot for cinemas at a time when moviegoing economics are under strain. For audiences, it signals Spider-Man: Brand New Day is a cultural event worth catching on the big screen, and it's a barometer for the health of the theatrical business.